Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border

Wongsrichanalai, Chansuda; Meshnick, Steven R.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border

Published Date:

May 2008

Source:

Emerg Infect Dis. 14(5):716-719.

[PDF - 98.59 KB]

Details:

Personal Authors:

Wongsrichanalai, Chansuda ; Meshnick, Steven R. ;

Keywords:

[+]

Description:

Resistance to many antimalaria drugs developed on the Cambodia-Thailand border long before developing elsewhere. Because antimalaria resistance is now a global problem, artemisinin-based combination therapies (ACTs) are the first-line therapies in most malaria-endemic countries. However, recent clinical and molecular studies suggest the emergence of ACT-resistant Plasmodium falciparum infections in the Cambodia-Thailand border area, where standard ACT is artesunate and mefloquine. These ACT failures might be caused by high-level mefloquine resistance because mefloquine was used for monotherapy long before the introduction of ACT. This observation raises 2 questions. First, how can existing P. falciparum-resistant strains be controlled? Second, how can the evolution of new ACT- resistant strains be avoided elsewhere, e.g., in Africa? Enforcement of rational drug use and improved diagnostic capacity are among the measures needed to avoid and contain ACT resistance.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Supporting Files:

07-1601-F.gif	image/gif
07-1601-F.jpg	image/jpeg
07-1601_finalS.nxml	text/plain
license.txt	text/plain

No Related Documents.

You May Also Like:

Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria

Personal Author:

Gutman, Julie; Green, Michael; Durand, Salomon; Rojas, Ofelia Villalva; Ganguly, Babita; Quezada, Wilmer Marquiño; Utz, Gregory C; Slutsker, Laurence; Ruebush, Trenton K; Bacon, David J;

Published:

Apr 09 2009

Source:

Malar J. 2009; 8:58.

Description:

Background : Artemisinin-based combination therapy (ACT) is recommended as a means of prolonging the effectiveness of first-line malaria treatment regimens. Different brands of mefloquine (MQ) have been reported to be non-bioequivalent; this could re...

File Type:

[PDF - 277.32 KB]
Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997–2007

Personal Author:

Vijaykadga, Saowanit; Alker, Alisa P; Satimai, Wichai; MacArthur, John R; Meshnick, Steven R; Wongsrichanalai, Chansuda;

Published:

Aug 28 2012

Source:

Malar J. 2012; 11:296.

Description:

Background : There is concern that artesunate resistance is developing in Southeast Asia. The purpose of this study is to investigate the prevalence of parasitaemia in the few days following treatment with artesunate-mefloquine (AM), which is an indi...

File Type:

[PDF - 599.29 KB]
In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014

Personal Author:

Paczkowski, Magdalena; Mwandama, Dyson; Marthey, Daniel; Luka, Madalitso; Makuta, Georgina; Sande, John; Ali, Doreen; Troell, Peter; Mathanga, Don P.; Gutman, Julie;

Published:

Apr 26 2016

Source:

Malar J. 15.

Description:

Background : Malaria causes significant morbidity in Malawi, with an estimated 5 million cases in 2014. Artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) are the first- and second-line treatments for uncomplicated malaria, respectively, ...

File Type:

[PDF - 1.08 MB]
Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015

Personal Author:

Plucinski, Mateusz M.; Dimbu, Pedro Rafael; Macaia, Aleixo Panzo; Ferreira, Carolina Miguel; Samutondo, Claudete; Quivinja, Joltim; Afonso, Marília; Kiniffo, Richard; Mbounga, Eliane; Kelley, Julia S.; Patel, Dhruviben S.; He, Yun; Talundzic, Eldin; Garrett, Denise O.; Halsey, Eric S.; Udhayakumar, Venkatachalam; Ringwald, Pascal; Fortes, Filomeno;

Published:

Feb 02 2017

Source:

Malar J. 16.

Description:

Background : Recent anti-malarial resistance monitoring in Angola has shown efficacy of artemether–lumefantrine (AL) in certain sites approaching the key 90% lower limit of efficacy recommended for artemisinin-based combination therapy. In addition...

File Type:

[PDF - 1.21 MB]
In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia

Personal Author:

Hwang, Jimee; Alemayehu, Bereket H; Hoos, David; Melaku, Zenebe; Tekleyohannes, Samuel G; Teshi, Takele; Birhanu, Sintayehu G; Demeke, Leykun; Gobena, Kedir; Kassa, Moges; Jima, Daddi; Reithinger, Richard; Nettey, Henry; Green, Michael; Malone, Joseph L; Kachur, S Patrick; Filler, Scott;

Published:

Jul 28 2011

Source:

Malar J. 2011; 10:209.

Description:

Background : In vivo efficacy assessments of the first-line treatments for Plasmodium falciparum malaria are essential for ensuring effective case management. In Ethiopia, artemether-lumefantrine (AL) has been the first-line treatment for uncomplicat...

File Type:

[PDF - 551.41 KB]